199 related articles for article (PubMed ID: 36253247)
1. Therapies in Autoimmune Peripheral Neuropathies beyond Intravenous Immunoglobulin, Plasma Exchange and Corticosteroids: An Analytical Review.
Sivadasan A; Bril V
Transfus Med Rev; 2022 Oct; 36(4):220-229. PubMed ID: 36253247
[TBL] [Abstract][Full Text] [Related]
2. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
3. Immune mediated neuropathies--an update on therapeutic strategies.
Czaplinski A; Steck AJ
J Neurol; 2004 Feb; 251(2):127-37. PubMed ID: 14991345
[TBL] [Abstract][Full Text] [Related]
4. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
[TBL] [Abstract][Full Text] [Related]
5. Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications.
Dziadkowiak E; Nowakowska-Kotas M; Rałowska-Gmoch W; Budrewicz S; Koszewicz M
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298132
[TBL] [Abstract][Full Text] [Related]
6. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies.
Lehmann HC; Hartung HP
J Neuroimmunol; 2011 Feb; 231(1-2):61-9. PubMed ID: 21056913
[TBL] [Abstract][Full Text] [Related]
7. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
Radziwill AJ; Kuntzer T; Steck AJ
Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
[TBL] [Abstract][Full Text] [Related]
8. [Autoimmune neuropathies: diagnosis, treatment, and recent topics].
Ueda M; Kusunoki S
Brain Nerve; 2011 Jun; 63(6):549-55. PubMed ID: 21613658
[TBL] [Abstract][Full Text] [Related]
9. The role of IVIg in autoimmune neuropathies: the latest evidence.
Hughes R
J Neurol; 2008 Jul; 255 Suppl 3():7-11. PubMed ID: 18685920
[TBL] [Abstract][Full Text] [Related]
10. Immune-mediated neuropathies.
Kieseier BC; Mathey EK; Sommer C; Hartung HP
Nat Rev Dis Primers; 2018 Oct; 4(1):31. PubMed ID: 30310069
[TBL] [Abstract][Full Text] [Related]
11. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression.
Hung SKY; Hiew FL; Viswanathan S; Puvanarajah S
J Peripher Nerv Syst; 2018 Sep; 23(3):183-189. PubMed ID: 30027593
[TBL] [Abstract][Full Text] [Related]
12. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Current Therapies and Future Approaches.
Svačina MKR; Lehmann HC
Curr Pharm Des; 2022; 28(11):854-862. PubMed ID: 35339172
[TBL] [Abstract][Full Text] [Related]
13. Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan.
Nobile-Orazio E; Gallia F; Terenghi F; Bianco M
Expert Rev Neurother; 2017 Aug; 17(8):755-765. PubMed ID: 28597710
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and management of immune-mediated neuropathies].
Hsieh ST
Acta Neurol Taiwan; 2004 Mar; 13(1):39-45. PubMed ID: 15315301
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA; Swan AV; van Doorn PA
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002063. PubMed ID: 25238327
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
Sederholm BH
Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
[TBL] [Abstract][Full Text] [Related]
17. Treatment approaches for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Lindenbaum Y; Kissel JT; Mendell JR
Neurol Clin; 2001 Feb; 19(1):187-204. PubMed ID: 11471764
[TBL] [Abstract][Full Text] [Related]
18. Initial and long-term management of autoimmune neuropathies.
Koski CL
CNS Drugs; 2005; 19(12):1033-48. PubMed ID: 16332144
[TBL] [Abstract][Full Text] [Related]
19. Treatment of immune-mediated inflammatory neuropathies.
Hadden RD; Hughes RA
Curr Opin Neurol; 1999 Oct; 12(5):573-9. PubMed ID: 10590894
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD002827. PubMed ID: 27701752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]